1 / 86

Drugs for Reproductive Endocrinology: Focus on OCP therapeutics

Drugs for Reproductive Endocrinology: Focus on OCP therapeutics Ma. Stephanie Fay S. Cagayan, MD, FPOGS. General Objective. To acquire an understanding of the action of the different sex hormones and other hormones utilized in the pharmacology of hormonal contraception

dylan-jimenez
Télécharger la présentation

Drugs for Reproductive Endocrinology: Focus on OCP therapeutics

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Drugs for Reproductive Endocrinology: Focus on OCP therapeutics Ma. Stephanie Fay S. Cagayan, MD, FPOGS

  2. General Objective To acquire an understanding of the action of the different sex hormones and other hormones utilized in the pharmacology of hormonal contraception Reference: Chapter 40, Basic and Clinical Pharmacology 1th edition (Katzung)

  3. Specific Objectives To be able to review the physiology of normal menstrual cycle To list the different sex hormones, know their biosynthesis (chemical compositions), mechanism of action, pharmacokinetic properties, physiologic and metabolic effects To describe clinical/therapeutic applications of these hormones To list side effects and/or adverse reactions to these drugs

  4. Outline Physiology of Reproductive Hormones Female Gonadal Hormones Estrogen and Progesterone ORAL CONTRACEPTION

  5. Different Hormones in Reproductive Endocrinology Biosynthesis (chemical compositions) Mechanism of action Pharmacokinetic properties Physiologic and Metabolic effects Clinical / Therapeutic Application Adverse Effects

  6. Outline Physiology of Reproductive Hormones Female Gonadal Hormones Estrogen and Progesterone ORAL CONTRACEPTION

  7. Sex hormones = gonadal hormones estrogens progestins androgens Gonadotropins LH FSH GnRH

  8. Gonadal Hormones SYNTHESIS OF SEX STEROIDS

  9. Gonadal Hormones SEX HORMONES: 21 carbon series – PROGESTINS (pregnane nucleus) 19 carbon series - ANDROGENS (androstane nucleus) 18 carbon series - ESTROGENS (estrane nucleus) What regulates the synthesis of sex hormones?

  10. Hypothalamic-Pituitary-Gonadal Axis

  11. Hypothalamic-Pituitary-Reproductive Axis: TWO CELL-SYSTEMS (Testosterone) (Androstenedione)

  12. Hypothalamic-Pituitary-Reproductive Axis: TWO CELL-SYSTEMS

  13. Prerequisites of Normal Menstruation an intact HPO axis estrogen-induced proliferative endometrium ovulation at midcycle progesterone-induced secretory endometrium if pregnancy does not occur, the hormones decline, and withdrawal bleeding occurs

  14. Major natural estrogens in human Actions mediated by ESTROGEN RECEPTORS (alpha and beta) which are ligand-regulated transcription factors The Estrogens

  15. Some synthetic estrogens

  16. The Estrogens Biosynthesis (chemical compositions) Mechanism of action Pharmacokinetic properties Physiologic and Metabolic effects Clinical / Therapeutic Application Adverse Effects

  17. Steroid Hormone and its Receptor

  18. Estrogen Receptor Actions mediated by ESTROGEN RECEPTORS (alpha and beta) which are ligand-regulated transcription factors

  19. The Estrogens: Pharmacokinetics Estradiol (E2) binds STRONGLY to α globulin (SHBG) LOWER affinity to albumin E2 (liver) → Estrone (E1) and Estriol(E3) → hydroxylated derivatives and conjugated metabolites Orally administered estrogens have HIGH ratio of hepatic to peripheral effects → responsible for the increased clotting factors and increased renin substrate

  20. Clinical / Therapeutic Application Primary hypogonadism Hormonal contraception Post-menopausal hormonal therapy

  21. The Estrogens Biosynthesis (chemical compositions) Mechanism of action Pharmacokinetic properties Physiologic and Metabolic effects Clinical / Therapeutic Application Adverse Effects

  22. Adverse Effects Uterine bleeding Endometrial cancer Other effects: nausea, breast tenderness

  23. The Natural Progestins: Progesterone • The most important progestin in human • Serves as a precursor to the estrogens, androgens and adrenocortical steroids • Synthesized in the ovary, testis and adrenal from circulating cholesterol; large amounts are also synthesized and released by the placenta during pregnancy

  24. The Synthetic Progestins 21 carbon compounds 19-nor, 13 ethyl compounds Hydroxyprogesterone acetate Medroxyprogesterone acetate Megestrol Dimethisterone * Most closely related to progesterone Desogestrel Gestodene Norgestimate ** claimed to have lower androgenic activity than older synthetic progestins

  25. Actions are mediated by progesterone receptors (A and B isoforms) which are ligand-activated transcription factors The concentration of progesterone receptors is dependent on previous estrogen action The Progestins

  26. The Progestins Biosynthesis (chemical compositions) Mechanism of action Pharmacokinetic properties Physiologic and Metabolic effects Clinical / Therapeutic Application Adverse Effects

  27. The Progestins: Pharmacokinetics Progesterone is rapidly absorbed following administration by any route t ½ is 5minutes Almost completely metabolized in one passage through the liver In the liver, it is metabolized to pregnanediol and conjugated with glucuronic acid It is excreted into the urine as pregnanediol glucuronide

  28. The Progestins Biosynthesis (chemical compositions) Mechanism of action Pharmacokinetic properties Physiologic and Metabolic effects Clinical / Therapeutic Application Adverse Effects

  29. Physiologic Effects • Decreases amount of cervical mucus and increases its viscosity • Increases basal body temperature Promote endometrial development during luteal phase

  30. Progesterone ATTENUATES estrogen action on the endometrium in 3 ways: The Physiologic Effect of Progestins By reducing the rate of synthesis of ER molecules By increasing the rate of enzymatic inactivation By effecting estrogen inactivation through sulfuration

  31. The Physiologic Effect of Progestins

  32. Physiologic Effects: Progesterone Has little effect on protein metabolism Has more marked effect on carbohydrate metabolism: progesterone INCREASES basal insulin levels and the insulin response to glucose Antagonize actions of aldosterone

  33. Physiologic Effects: Progesterone Increases body temperature Has depressant and hypnotic effects on the brain Increases ventilatory response to CO2 Stimulate growth and development of breasts during pregnancy Its effects on the uterus are essential for maintenance of pregnancy

  34. Clinical Application THERAPEUTIC APPLICATION: Hormonal contraception Hormonal replacement therapy Endometriosis

  35. Clinical Application: D I A G N O S T I C A test of estrogen secretion: Progesterone challenge test - MPA 10mg/d for 5 days - when endometrium has been stimulated by estrogens   (+) withdrawal bleeding

  36. Adverse Effects Headache Dizziness Bloating Weight gain Reversible reduction of glucose tolerance

  37. Hormonal contraception in women Combination of progestins and estrogens – Combination oral contraceptives (COCs) Progestin only pills (POPs)

  38. The Pharmacology of the Estrogen Component of COCs E2 is the most potent natural estrogen --- inactive orally E2 + ethinyl group at the 17 position = Ethinyl Estradiol --- orally active

  39. The Pharmacology of the Estrogen Component of COCs Metabolism of EE VARIES SIGNIFICANTLY from individual to individual, and from one population to another ESTROGEN CONTENT of the pill is of major clinical importance ---- THROMBOSIS is dose-related DOSE OF ESTROGEN – a critical issue in selecting an oral contraceptive

  40. COMBINATION ORAL CONTRACEPTIVES (COCS) – PROGESTIN COMPONENT 42

  41. The Pharmacology of the Progestin Component of COCs 2 major types of synthetic progestins Derivatives of 19 nortestosterone Derivatives of 17α acetoxyprogesterone

  42. The Pharmacology of the Progestin Component of COCs NORETHINDRONE ETHISTERONE TESTOSTERONE Removal of 19-carbon from ethisterone formed NORETHINDRONE → changed major hormonal effect from an androgen to progestational agent → 19 nortestosterone - all progestational agents have some degree of androgenic activity

  43. The Pharmacology of the Progestin Component of COCs 19 NORTESTOSTERONE ESTRANES Norethindrone Norethynodrel Norethindrone acetate Ethynodiol acetate GONANES Levonorgestrel Norgestimate* Gestodene* Desogestrel* * With greater progestational activity

  44. The Pharmacology of the Progestin Component of COCs Other progestins • Levonorgestrel is the active isomer of norgestrel New progestins • Desogestrel, gestodene, norgestimate are derivatives of levonorgestrel • Reduced androgenicity (increased sex hormone binding globulin, decreased free testosterone) • Drospirenone – analogue of spironolactone, has affinity for mineralocorticoid receptor and antimineralocorticoid effect (Yasmin)

  45. The Pharmacology of the Progestin Component of COCs 17 α ACETOXYPROGESTERONE C21 progestins PREGNANES Structurally related to progesterone Medroxyprogesterone acetate and megestrol acetate Marketed for noncontraceptive usage

  46. COCs “ Current formulations of COCs are made from SYNTHETIC steroids and contain no natural estrogens or progestins.”

  47. syntheticprogestins Ethinyl estradiol

  48. Definitions Low Dose Oral Contraceptives – products with <50ug of EE 1st generation COCs – products with > 50ug of EE 2nd generation COCs – products with levonorgestrel,norgestimate, and other members of the norethindrone family and <50ug EE 3rd generation COCs – products with desogestrel or gestodene and <50ug of EE

More Related